Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings (Q30980756)

27 June 2017

1 reference

title

Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings (English)

1 reference

27 June 2017

1 reference

0 references

Peter H Silverstone

1

1 reference

PubMed ID

15654927

27 June 2017

Brent M McGrath

series ordinal

2

1 reference

PubMed ID

15654927

27 June 2017

Hyeonjin Kim

series ordinal

3

1 reference

27 June 2017

1 February 2005

1 reference

27 June 2017

1 reference

27 June 2017

7

1 reference

27 June 2017

1

1 reference

27 June 2017

1-10

1 reference

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

27 June 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Lamotrigine: a depression mood stabiliser.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Chronic lithium treatment attenuates intracellular calcium mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Magnetic resonance spectroscopy and its applications in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Lithium and myo-inositol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Increased brain myo-inositol 1-phosphate in lithium-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Inositol phosphates and cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Changes in the 31P-NMR spectra of cats receiving lithium chloride systemically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Decreased N-acetylaspartate in children with familial bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled (31)P magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

A common mechanism of action for three mood-stabilizing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2004.00174.X

10.1111/J.1399-5618.2004.00174.X

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference

PubMed ID

15654927